OrbiMed Asia Partners IV Overview
- Fund Strategy
-
Growth/Expansion
- Fund Status
-
Closed
- Fund Manager
- OrbiMed
- Size
-
$800M
- Vintage
-
2021
- Dry Powder
-
OrbiMed Asia Partners IV General Information
Description
OrbiMed Asia Partners IV is a private equity growth and expansion fund managed by OrbiMed. The fund is located in Shanghai, China.
Contact Information
Fund Manager's Location
- Unit 2701, Jing An Kerry Centre, Office Tower 3
- 1228 Yanan Middle Road
- Shanghai, 200040
- China
OrbiMed Asia Partners IV Investments (6)
OrbiMed Asia Partners IV has made a total of 6 investments. Its most recent deal was a with Sirius Therapeutics for . The deal was made on 09-May-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Sirius Therapeutics | 09-May-2025 | Drug Discovery | Pre-Clinical Trials | |||
| LifeCell (Healthcare Services) | 21-Sep-2021 | Other Healthcare Services | Generating Revenue | |||
| Vigil Neuro | 13-Aug-2021 | Drug Discovery | Clinical Trials - Phase 1 | |||
| Nautilus Biotechnology | 09-Jun-2021 | Biotechnology | Generating Revenue | |||
| Adela | 31-Mar-2021 | Early Stage VC (Series A) | Decision/Risk Analysis | Generating Revenue |
OrbiMed Asia Partners IV Investment Strategy
Investments by Industry
Investments by Deal Type
OrbiMed Asia Partners IV Limited Partners (5)
Asian Development Bank is one of OrbiMed Asia Partners IV’s 5 limited partners. Its latest Original was on 03-Mar-2021.
| Limited Partner Name | Type | Status | Commitment | Date | Commitment Type |
|---|---|---|---|---|---|
| Asian Development Bank | Current | 03-Mar-2021 | Original | ||
| Michigan State University Endowment | Current | 03-Mar-2021 | Original | ||
| Texas Tech University System Endowment | Current | 03-Mar-2021 | Original | ||
| The Leona M. and Harry B. Helmsley Charitable Trust | Current | 03-Mar-2021 | Original | ||
| Wyncote Foundation | Foundation | Current | 03-Mar-2021 | Original |
OrbiMed Asia Partners IV Returns Data
The below charts are illustrative of the type of graphical data available to our clients and do not represent live data.
IRR (%)
DPI (x)
RVPI (x)
TVPI (x)
OrbiMed Asia Partners IV Returns History
| Period | Contribution (by all LPs) | Dry Powder | Distribution (to all LPs) | NAV | Total Fund Distr+NAV | IRR | DPI | RVPI | TVPI | Dry Powder % |
|---|
OrbiMed Asia Partners IV Benchmark (12)
| Fund Name | Fund Type | Vintage | IRR | Quartile | As of Date |
|---|---|---|---|---|---|
| Gaocheng Fund II | 30-Jun-2026 | ||||
| PAG China Growth Fund II | |||||
| Navis Asia Fund VIII | |||||
| Shanghai Healthcare Capital USD Fund I | |||||
| LBC Sunshine Healthcare Fund II | |||||
| Ocean Link Partners II | |||||
| OrbiMed Asia Partners IV | 31-Mar-2026 | ||||
| Multiples Private Equity Fund III | 31-Dec-2022 | ||||
| Carlyle Asia Partners Growth II | 31-Mar-2026 | ||||
| TPG Strategic Capital Fund | 30-Sep-2023 |
OrbiMed Asia Partners IV FAQs
-
What is OrbiMed Asia Partners IV?
OrbiMed Asia Partners IV is a private equity growth and expansion fund managed by OrbiMed.
-
Who manages OrbiMed Asia Partners IV?
OrbiMed Asia Partners IV is managed by OrbiMed.
-
Where is OrbiMed Asia Partners IV domiciled?
OrbiMed Asia Partners IV is domiciled in Cayman Islands.
-
What is OrbiMed Asia Partners IV's size?
OrbiMed Asia Partners IV has a size of $800M.
-
What type of fund is OrbiMed Asia Partners IV?
The fund type of OrbiMed Asia Partners IV is Growth/Expansion.
-
What is the status of OrbiMed Asia Partners IV?
OrbiMed Asia Partners IV is closed.
-
What has OrbiMed Asia Partners IV invested in?
OrbiMed Asia Partners IV has made numerous investments in companies like Sirius Therapeutics, LifeCell (Healthcare Services), and Vigil Neuro within the Drug Discovery and Healthcare Services industries.
-
What has OrbiMed Asia Partners IV invested in recently?
OrbiMed Asia Partners IV's latest investment was on 09-May-2025 in Sirius Therapeutics, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
